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Abstract
Background:  We studied the application of the BCR-ABL1  + 9q34 tri-colour dual fusion
fluorescence in situ hybridization (FISH) system in the characterization of fusion signal pattern and
the monitoring of residual disease in chronic myelogenous leukaemia (CML). The signal
constellation on metaphases with the tri-colour dual fusion system was defined. The knowledge of
various signal patterns obtained from the different genetic rearrangements was further applied to
the analysis of hybridization signals on interphase nuclei.
Methods: BCR-ABL1 dual colour, dual fusion FISH (D-FISH) was performed on diagnostic samples
of 22 CML patients. The tri-colour FISH system was performed on cases that showed aberrant
signal patterns other than the classical 1 green (G) 1 orange (O) 2 fusions (F). Using the aqua band-
pass filter, random signal overlap in interphase nuclei would be indicated by the presence of an aqua
signal (ASS1), while genuine fusion was represented by the absence of the ASS1 signal.
Results: Using the D-FISH system, the signal patterns could be categorized into 4 groups: group
1 (n = 17) showed the classical 1G1O2F; group 2 (n = 2) showed 2G1O1F indicating ABL1 deletion;
group 3 (n = 1) showed 1G2O1F indicating BCR deletion; group 4 (n = 2) with 1G1O1F indicating
reciprocal ABL1-BCR deletion. The tri-colour dual fusion system correlated with the D-FISH system
for cases with der(9) deletion. The added aqua-labelled ASS1 probe was useful in differentiating
random signal overlap from genuine BCR-ABL1 fusion in the interphase cells (group 4).
Conclusion: Although the D-FISH probe was valuable in establishing the different patterns of
aberrant signals and monitoring patients with the classic 2-fusion signals in CML, the tri-colour dual
fusion probe should be used for patients with der(9) deletion to monitor response to treatment.
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Background
Chronic myelogenous leukaemia (CML) is a clonal hae-
matopoietic stem cell disorder characterized by the trans-
location t(9;22)(q34;q11.2). The translocation fuses the
5' sequences of the BCR gene on chromosome 22 with the
3' sequences of the ABL1 gene on the chromosome 9. The
dual colour, dual fusion fluorescence in situ hybridization
(D-FISH) system can demonstrate the BCR-ABL1 fusion
[1]. In classical t(9;22), there is one signal each for the
wild type alleles and two fusion signals, one for the fusion
gene and the other for the reciprocal product in a positive
cell. This dual fusion pattern has provided good analytical
sensitivity for the monitoring of disease response to ther-
apy. However, around 15% of CML patients show dele-
tion of the reciprocal ABL1-BCR fusion on the derivative
chromosome 9 (der(9) deletion), often with loss of both
chromosomes 9 and 22 sequences on either side of the
breakpoint [2-4]. The der(9) deletion is associated with an
inferior outcome when compared with those without
such deletion, but the poor prognosis may at least be par-
tially abrogated by imatinib therapy [5]. In the presence of
der(9) deletion, false positivity is a problem with the use
of dual colour single or even dual fusion probes. In this
study, we have used metaphase FISH to study the signal
pattern on diagnostic samples of 22 CML patients. In
addition, the BCR-ABL1 + 9q34 tri-colour, dual fusion sys-
tem was applied on all cases with atypical D-FISH pattern
and also in the monitoring of residual disease in a patient
with der(9) deletion.
Methods
The diagnostic samples, including both peripheral blood
and bone marrow from 22 CML patients were retrieved
for the study. Cytogenetics study on all the samples
showed t(9;22)(q34;q11.2). BCR-ABL1 dual colour dual
fusion FISH (D-FISH) (Vysis, Abbott Molecular Inc., IL)
was performed on cell pellets kept in Carnoy's fixative that
were previously processed for cytogenetics analysis. For
cases with aberrant signal pattern other than the classical
1 green (G), 1 orange (O) and 2 fusions (F), the BCR-ABL1
+ 9q34 tri-colour dual fusion FISH (Vysis) system was
applied to further characterize the signal pattern.
Briefly, cells were dropped onto microscopic slides and
aged overnight at 65°C before performing the FISH
hybridization procedures according to manufacturer's
protocol. 10 μl of the probe mixture was applied to a 18 ×
18 mm hybridization area. The hybridized area was sealed
with rubber cement to avoid drying in subsequent dena-
turation and hybridization procedure. The chromosomes
and probes were co-denatured at 75°C for 5 minutes and
allowed to hybridize overnight at 37°C (Hybridizer,
DakoCytomation). Slides were washed in 0.4× SSC/0.3%
NP40 at 70°C for 2 minutes followed by 2× SSC/0.1%
NP40 at room temperature for 1 minute. The wash step
was necessary to remove non-specific hybridization sig-
nals. Slides were then counterstained and mounted with
10 μl 4',6-diamidino-2-phenylindole (DAPI II, 125 ng/
ml, Vysis).
For each hybridization experiment, 200 interphase cells
were examined under oil immersion at 1000× magnifica-
tion using the Nikon (model 80i) fluorescence micro-
scope. The FISH signals were analyzed with
fluorochrome-specific single band-pass filters for the BCR
(SpectrumGreen signals) and ABL1 (SpectrumOrange sig-
nals). The BCR-ABL1 fusion signals were scored with a
dual band-pass filter. For the tri-colour dual fusion sys-
tem, cells were further examined using a single band-pass
filter specific for the ASS1 (SpectrumAqua signals). Signal
patterns in both interphase and metaphase were charac-
terized using both D-FISH and tri-colour dual fusion FISH
system. The Cytovision imaging workstation (Version
2.7) was used for image capture and processing.
This study was performed according to the regulation set
by the Ethics Committee of Queen Elizabeth Hospital.
Results
The probe configuration for both the D-FISH and the tri-
colour dual fusion FISH were shown in Figure 1. In classi-
cal t(9;22), there was fusion of the BCR on chromosome
22 with the ABL1 on chromosome 9. The D-FISH system
showed individual orange and green signals from the nor-
mal 9 and 22 chromosomes and two orange/green fusion
(F) signals, one each from the derivative 9 and 22 chro-
mosomes. In the tri-colour dual fusion system, an addi-
tional  ASS1  gene (centromeric to the ABL1) on
chromosome 9 was labeled with SpectrumAqua. The
probe target on the normal chromosomes 9 and 22 was
expected to produce single orange/aqua and green signals
respectively. Thus, the der(22) was visible as an orange/
green fusion signal without an associated aqua signal. The
der(9) had an orange/aqua/green fusion signal. Since the
ASS1 was not involved in the translocation, the aqua sig-
nal was present when there was random juxtaposition of
chromosome 9 and 22 but not in genuine BCR-ABL1
fusion.
Using the D-FISH system, our patients could be catego-
rized into 4 groups (Figure 2, A – D, upper panel): group
1 (n = 17) showed the classical pattern of 1G1O2F; group
2 (n = 2) showed 2G1O1F indicating ABL1  deletion;
group 3 (n = 1) showed 1G2O1F indicating BCR deletion;
group 4 (n = 2) with 1G1O1F indicating reciprocal ABL1-
BCR deletion. Using the tri-colour dual fusion system, the
added aqua-labelled ASS1 was found on the normal chro-
mosome 9 and the der(9) but not in the der(22) (Figure
2, A – D, lower panel). In cases with der(9) deletion,
either the ASS1/ABL1 signal or the BCR signal could beBMC Blood Disorders 2009, 9:4 http://www.biomedcentral.com/1471-2326/9/4
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deleted. Similarly, in cases with reciprocal ABL1-BCR dele-
tion, the aqua/orange/green signal was not detected on
der(9). Nevertheless, the scoring of 'single-fusion' signal
on der(22) in interphase cells remained specific and
showed the same sensitivity as the use of D-FISH in classi-
cal 1G1O2F signal pattern. This was because genuine
fusion would consist of orange and green signals without
the aqua signal. In contrast, random signal overlap due to
juxtaposition of chromosome 9 and 22 would show up as
an orange/aqua/green signal. Thus, the potential false
positivity of D-FISH in case of reciprocal ABL1-BCR dele-
tion could be excluded. The tri-colour FISH was in fact,
superior to the D-FISH system in the analysis of low num-
bers of interphase cells with reciprocal ABL1-BCR deletion
that showed 1G1O1F signal pattern.
The tri-colour dual fusion system was used to study a case
with discrepant D-FISH and real-time quantitative reverse
transcriptase polymerase chain reaction (RQ-RTPCR)
results in a patient with reciprocal ABL1-BCR deletion.
The patient was a 51 year-old male who was diagnosed
with chronic myelogenous leukaemia in chronic phase in
June 2006. He was commenced on 400 mg imatinib daily
with complete haematological response and resolution of
splenomegaly within 2 months. Interphase D-FISH on
peripheral blood was used for residual disease monitor-
ing. Major cytogenetic response was achieved within 6
months with 7% fusion signals by interphase D-FISH.
After one year of imatinib treatment, the interphase D-
FISH still showed 9% fusion signals. RQ-RTPCRwas per-
formed, showing major molecular response with normal-
ized  BCR-ABL1  transcript level of 0.009% in the
international scale. FISH was repeated using the tri-colour
dual fusion system. Fusion signal was not found, thus
indicating falsely positive D-FISH results tested previously
(Figure 3, A – B).
Discussion
Interphase FISH is being used increasingly for the diagno-
sis and therapeutic monitoring of CML. Despite the sim-
plicity and rapid turn-around-time of the test,
inappropriate interpretation of signal pattern may com-
FISH Probe configuration Figure 1
FISH Probe configuration. (A) BCR-ABL1 dual colour, dual fusion (D-FISH). (B) BCR-ABL1 + 9q34 tri-colour, dual fusion.BMC Blood Disorders 2009, 9:4 http://www.biomedcentral.com/1471-2326/9/4
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Representative interphase and metaphase images from the four pattern of signals Figure 2
Representative interphase and metaphase images from the four pattern of signals. The upper panels are probe and 
reverse DAPI images using the BCR-ABL1 dual colour, dual fusion (D-FISH). The lower panels are probe and the cartoon 
images using the BCR-ABL1 tri-colour, dual fusion. (A) Group 1: classical 1G1O2F signal pattern using D-FISH. (B) Group 
2:ABL1 deletion, 2G1O1F signal pattern using D-FISH. (C) Group 3: BCR deletion, 1G2O1F signal pattern using D-FISH. (D) 
Group 4: reciprocal ABL1-BCR deletion, 1G1O1F signal pattern using D-FISH.BMC Blood Disorders 2009, 9:4 http://www.biomedcentral.com/1471-2326/9/4
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promise the sensitivity of the test [6]. Technically, this can
be due to poor hybridization signal or the presence of
undesirable background. Moreover, the interpretation is
sometimes difficult due to the inherent nature of signal
integrity (e.g. split signals) and signal overlap. With the
application of BCR-ABL1 D-FISH probe, the false positive
rate due to signal overlap has been reduced to < 1% in
comparison to the single fusion BCR-ABL1 probe [7].
Deletion of the ABL1 gene on der(9) has been shown to
be a poor prognostic marker in CML [3,4] although its
effect can be overcome by the use of imatinib [5]. Differ-
ent types of submicroscopic deletion of the BCR and/or
ABL1  have been well characterized with various BCR-
ABL1  probe system [8,9]. However, most studies have
focused on the fusion signal pattern on interphase cells
and few have applied the BCR-ABL1 + 9q34 tri-colour
FISH probe system [1,10]. In this study, we have used D-
FISH and tri-colour dual fusion system to study both met-
aphase and interphase signal patterns. The parallel analy-
sis of both FISH system on metaphase has not been
reported previously. Our result provides the basic ground-
work towards the better understanding of the various
BCR-ABL1  deletions and the correct interpretation of
interphase FISH signals.
The D-FISH system is adequate for the diagnosis and ther-
apeutic monitoring of CML with the classical t(9;22)
(1G1O2F pattern) (Figure 2A, upper panel) and even for
cases with ABL1 or BCR deletion, because in the latter, the
single genuine fusion can be readily differentiated from
random signal overlap due to the 'extra' green or orange
signal (Figure 2B–C, upper panel). In addition, the D-
FISH gives very reliable and specific delineation of the dif-
ferent signal patterns in metaphases (Figure 2A–D, upper
panel). It is, however, difficult to differentiate random sig-
nal overlap from genuine fusion in cases with reciprocal
ABL1-BCR deletion which will have 1G1O1F signal pat-
tern in positive cells when tested by D-FISH (Figure 2D,
upper panel). This single fusion pattern is often not a
problem when the diagnostic sample is tested because the
abnormal signal pattern is present in most interphase cells
[11]. However, when interphase FISH is performed for
disease monitoring, an atypical D-FISH result should be
confirmed by the tri-colour dual fusion system. This is
because the added aqua-labeled ASS1 probe consistently
allows the discrimination of random signal overlap from
genuine BCR-ABL1 fusion by the lack of aqua signal in the
der(22) as the ASS1 is not involved in the t(9;22) and will
remain in the der(9). The tri-colour dual fusion system is
particularly useful in the study of reciprocal ABL1-BCR
deletion where the signal pattern of 1G1O1F may some-
times be seen in a normal cell with random signal overlap.
We have used the tri-colour dual fusion probe system to
investigate the discrepant D-FISH and RQ-RTPCR result in
a patient with reciprocal ABL1-BCR deletion. The tri-col-
our system did not show any fusion signal and the major
molecular response was confirmed (Figure 3).
Conclusion
While the D-FISH system can reliably detect BCR-ABL1
gene fusions, it is sometimes impossible to differentiate
variant BCR-ABL1 and to exclude random signal overlap.
For cases with atypical fusion signals due to events such as
deletion of the ABL1  and/or  BCR, complex BCR-ABL1
rearrangement and supernumerary Philadelphia (Ph), tri-
colour dual fusion system can be used to further confirm
the presence of BCR-ABL1 gene fusion. Finally, the tri-
color dual fusion system should be recommended for
monitoring residual disease in CML patients with der(9)
deletion due to the superior analytical sensitivity over D-
FISH in this group of patients.
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Residual disease monitoring in patient with reciprocal ABL1-BCR deletion Figure 3
Residual disease monitoring in patient with reciprocal ABL1-BCR deletion. (A) Interphase BCR-ABL1 D-FISH shows 
random signal overlap that could be mistakenly scored as fusion signal. (B) Interphase BCR-ABL1 tri-colour dual fusion shows 
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